Feed - News and features

• Trial finds Lilly’s Olumiant could treat type 1 diabetes
  Treatment with Eli Lilly’s JAK...
• Sanofi says new drugs can add €10bn to sales by 2030
  Sanofi said this morning that its...
• AbbVie swoops on Pfizer spin-out Cerevel with $8.7bn offer
  AbbVie has announced its second major...
• Taisho says $5bn management buyout will rev up business
  Japan’s Taisho Pharmaceutical looks...

PharmaTimes: News RSS

• Secretary of state sets out priorities for UK health and social care systems
• Study reveals motor neuron region is affected in ALS
• KCL molecular communication system to revolutionise drug delivery
• NIHR invests £55m to tackle health inequalities and outcomes
• Brain waves found in sleep shown to protect against epileptic activity

• Relaunched EMA website now live
• EU medicines agencies reflect on lessons learned from COVID-19
• Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
• Consumption of antimicrobials in animals reaches lowest level ever in Europe

• A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects
• Social Transfers for Exclusive Breastfeeding in Brazil
• Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease
• Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment